Radiation dose to patients from radiopharmaceuticals : addendum 2 to ICRP publication 53, also includes addendum 1 to ICRP publication 72
Author(s)
Bibliographic Information
Radiation dose to patients from radiopharmaceuticals : addendum 2 to ICRP publication 53, also includes addendum 1 to ICRP publication 72
（ICRP publication, 80）（Annals of the ICRP, v. 28 no. 3）
Published for The Commission by Pergamon Press, c1999
Available at / 9 libraries
-
No Libraries matched.
- Remove all filters.
Description and Table of Contents
Description
ICRP Publication 80 provides biokinetic models, absorbed doses, effective doses, using ICRP Publication 60 dosimetry, for 10 new radiopharmaceuticals. It also provides recalculated dose data for the 19 most frequently used radiopharmaceuticals from ICRP Publication 53, using ICRP Publication 60 dosimetry, and corrects various printing errors in ICRP Publication 53. Furthermore, the report reproduces with minor corrections and updates, and therefore supersedes, Addendum 1 to ICRP Publication 53. An integrated index to all radiopharmaceuticals treated in ICRP Publications so far includes a listing of effective doses per unit activity administered to adults. The report also includes an Addendum to ICRP Publication 72 concerning age dependent doses to members of the public from intakes of radionuclides.
Table of Contents
Preface. Introduction. Effective dose. Remaining organs. Colon. Oesophagus. Blood model. Presentation of data. References for Introduction. Biokinetic models, absorbed doses, and effective doses for individual radiopharmaceuticals. Carbon-11-labelled thymidine. Carbon-14-labelled urea. Oxygen-15-labelled water. Technetium-labelled human immunoglobulin (HIG). Pertechnegas. Technegas. Technetium-labelled tetrofosmin (Myoview). Indium-labelled human immunoglobulin (HIG). Indium-labelled octreotide. Recalculated dose data for 19 frequently used radiopharmaceuticals from ICRP Publication 53. Introduction to Recalculations. 2-fluoro-2-deoxy-d-glucose (FDG). Chromium EDTA. Gallium citrate. Selenium-labelled bile acid (SeHCAT). Technetium-DMSA. Technetium-DTPA. Technetium-labelled erythrocytes (RBC). Technetium-labelled iminodiacetic acid(IDA) derivatives. Technetium-labelled large colloids. Technetium-labelled leucocytes (WBC). Technetium-labelled macroaggregated albumin (MAA). Technetium-labelled non-absorbable markers. Pertechnetate. Technetium-labelled phosphates and phosphonates. Hippuran. Metaiodobenaylguanidine. Iodomethyl-19-norcholesterol (NP 59). Thallous ion. Reprinting of biokinetics and dose data from Addendum 1 to ICRP Publication 53. Introduction to this updated version of Addendum 1. Tritum labelled neutral fat and free fatty acids. Carbon-14-labelled neutral fat and free fatty acids. Gallium-labelled EDTA. mechnetium-labelled HM PAO (Ceretec). Technetium-labelled mercaptocetyl triglycine (MAG3). Technetium-labelled MIBI. Index to and effective dose per unit administered activity for all radiopharm
by "Nielsen BookData"
